Trump announces deal on weight loss drug prices
Digest more
The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for
At no point on Thursday did anyone from the administration mention Medicare drug price negotiations, a key part of the Inflation Reduction Act which allows federal officials to negotiate the price of certain drugs. Trump has ridiculed the program, and no Republicans voted for the IRA when it passed in 2022.
Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back to the pod to discuss CMS' final guidance for the latest round of the Medicare drug price negotiation program.
Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the same active ingredient: semaglutide. Those treatments ...
WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price negotiations soon.
The Biden administration is working on forcing the pharmaceutical industry to lower the cost of popular drugs for Medicare Part D recipients. A federal judge has ruled against the pharmaceutical industry in its attempt to get the court to say the Biden ...
The report finds that the combined impact of actual 2026 Medicare Part D negotiated drug prices and expected 2027 prices through will negatively impact access to prescription drugs.